(1)
Starczewski, Łukasz; Osiński, D.; Kawa, Z.; Kasprzak, M.; Jędrzejewska, A.; Jureczko, A.; Kleczaj, K.; Jaworowska, J.; Babiarz, G.; Kanarszczuk, J. Clinical Efficacy, Mechanism of Action, and Adverse Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes – a Systematic Review. Qual Sport 2026, 54.